PAP Impasse Resolving? Lilly, J&J, AstraZeneca Working With Part D
Executive Summary
Lilly, Johnson & Johnson and AstraZeneca are extending their patient assistance programs (PAPs) to Medicare Part D enrollees who meet certain requirements, at least on an interim basis